2024 SCAI SHOCK

Mortality from cardiogenic shock complicating myocardial infraction remains high, approaching or exceeding 50% throughout the past 30 years, despite the development of percutaneous mechanical circulatory support technology and the national standard of emergent angioplasty and stenting.

SCAI SHOCK serves as a setting where the current diagnosis and management techniques of cardiogenic shock using the SCAI SHOCK classification system can be shared and discussed. 

Through lectures, case-based presentations, breakout sessions, and simulations, attendees gain knowledge and practical know-how they can apply to daily practice. 

Find out more about the sponsorship opportunities available!

At SCAI SHOCK, you can showcase your organization in various ways, including advertising, exhibiting, sponsoring a satellite symposium, and sponsoring promotional opportunities. Additional benefits are available to SCAI's corporate community. 

SCAI appreciates the vision and continued support of the following corporate community members.